With this Collection, a partnership between Nature Communications, Communications Medicine, Communications Biology, and Scientific Reports, we welcome submissions of primary research papers that focus on immune cell engineering for cancer therapy. The journals are particularly interested in preclinical studies proposing new engineering strategies and therapeutic developments.